Holger Schünemann

Yes

As part of his regular clinical practice, Dr. Schünemann is co-founder and co-owner of Start Prevention, a digital education platform focused on knowledge translation and mobilization of evidence-based preventive health recommendations for the public. Start Prevention operates independently of commercial interests and does not receive funding, sponsorship, or financial support from for-profit entities, including pharmaceutical, supplement, or medical device industries. So far no direct revenue has been generated by that activity beyond revenue for clinical care. I am a consultant to the European Commission and the Singapore Agency for clinical effectiveness.

Yes

I am a member of the scientific advisory board for the WHO Euro. Humanitas University employee; I am co-chair of the GRADE Working Group and immediate past chair of the Guidelines International Board of Trustees (2023-2025). I continue to contribute to the development of GRADEpro which is GRADE’s official product to apply and implement the GRADE approach; as such I have an interest that GRADEpro is further developed as GRADE and guideline methodology advances. GRADEpro is programmed by EvidencePrime and I provide advice to EvidencePrime. I have not received any payments from EvidencePrime which is owned in part by McMaster University and EvidencePrime has received funding from McMaster University (through research grants and contracts) to do the programming on GRADEpro but GRADEpro is only one of several products EvidencePrime produces. I am creator and Head of the steering committee for the new G-I-N-McMaster Guideline Credentialing and Certification Program: INGUIDE. I am chair of the working group for the European commission colorectal cancer, and lung cancer initiatives.

Yes

In the past we have received funding for methods projects from Cochrane. I have also been on the board and a methods group executive member.

No